Large-cell immunoblastic lymphoma
MONDO:0022037Malignant lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, one or more prominent nucleoli, and abundant cytoplasm. This class may be subdivided into plasmacytoid and clear-cell types based on cytoplasmic characteristics. A third category, pleomorphous, may be analogous to some of the peripheral T-cell lymphomas (LYMPHOMA, T-CELL, PERIPHERAL) recorded in both the United States and Japan.
Also known as: Diffuse Immunoblastic Lymphosarcoma, Diffuse Immunoblastic Lymphosarcomas, Diffuse non-Hodgkin lymphoma, immunoblastic, Diffuse non-Hodgkin's immunoblastic (diffuse) lymphoma, Diffuse non-Hodgkin's lymphoma, immunoblastic, Diffuse non-Hodgkin's lymphoma, immunoblastic (clinical), IMMUNOBLASTIC LARGE LYMPHOMA, Immunoblastic Large Cell Lymphoma
1930 clinical trials for this condition and its sub-types, 9 tagged with Large-cell immunoblastic lymphoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New registry aims to unlock secrets of cancer in older adults
Knowledge-focused Recruiting nowThis research study creates a registry of older adults with cancer to collect information about their health, treatments, and outcomes. Participants complete a geriatric assessment and allow researchers to follow their medical records. The goal is to better understand how cancer …
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Blood cancer Patients' samples fuel future research
Knowledge-focused Recruiting nowThis study collects blood, tissue, and body fluid samples from up to 15,000 people with blood cancers or related disorders. The samples are stored in a central lab for future research on diagnosis, prognosis, and immune monitoring. Participants do not receive any treatment as par…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC